ISO 13485:2016 certified · Startup India (DPIIT) recognised · NVIDIA Inception program member +91 44 4690 0555info@medoqi.tech
Latin America · Brazil

Notification or registration with ANVISA through a Brazilian Registration Holder.

Classification, notification or registration, Brazilian GMP certification, and INMETRO certification where it applies.

Discuss your Brazilian market entry →Last reviewed October 2026
Regulatory overview

Key facts

AuthorityAgência Nacional de Vigilância Sanitária (ANVISA)
LegislationRDC 751/2022 (medical devices); RDC 830/2023 (IVDs); RDC 665/2022 (GMP)
Device classesClass I to IV
IVD classesClass I to IV
Quality systemBrazilian GMP (RDC 665/2022); MDSAP reports used
Local representationBrazilian Registration Holder
Market authorisation

Pathways

  • Class I and II: notification (notificação)
  • Class III and IV: registration (registro)
  • INMETRO certification for certain electromedical devices
  • Brazilian GMP certification by ANVISA for Class III and IV manufacturers
Documentation

What you will need

  • Technical dossier per ANVISA requirements
  • Labelling and IFU in Portuguese
  • Brazilian GMP certificate (Class III and IV)
  • INMETRO certificate where required
Registration process

Sequence and decision points

  1. 01ClassifyApply RDC 751/2022 or RDC 830/2023 rules.
  2. 02Appoint a BRHA local holder with ANVISA company authorisation.
  3. 03CertifyBrazilian GMP and INMETRO where required.
  4. 04SubmitNotification or registration dossier.
  5. 05Market and monitorTechnovigilance and renewals.
Quality system

Brazilian GMP (RDC 665/2022). ANVISA certification is required for Class III and IV and can draw on MDSAP audit reports.

Local representation

A Brazilian Registration Holder, a local company with ANVISA authorisation, must hold the notification or registration.

Where MedoQi does not hold this role, we work with your appointed representative or a qualified partner.

Timelines and fees

ANVISA fees depend on class and company size. GMP certification and INMETRO can be the longest lead items.

Post-market obligations

After market entry

  • Technovigilance reporting to ANVISA
  • Field actions and recalls
  • Registration renewal for Class III and IV
  • Change notifications
MedoQi services

How we help

  • Classification and pathway strategy
  • Brazilian GMP readiness and MDSAP alignment
  • Dossier preparation support
  • BRH coordination
  • Technovigilance support

Delivered through our model: assess, validate, remediate, submit, maintain. How we work

FAQ

Common questions about Brazil

Summary information for orientation. Requirements depend on intended use, classification and device characteristics, and change over time.

Can MDSAP help with Brazilian GMP?

Yes. ANVISA participates in MDSAP and can use MDSAP audit reports in its GMP certification process.

Talk to our experts

Discuss your device, market or audit with a specialist

Share the device, its class and your target markets. A senior specialist will come back with the likely pathway, the evidence gaps we see and a practical plan.

Talk to our experts → Request an AI pilot sales@medoqi.tech · +91 44 4690 0555